Publication | Closed Access

Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation

InflammationAllergyLung InflammationAllergy MedicineMedicineImmunologyMurine ModelsTherapeutic EfficacyPulmonary PharmacologyAutoimmunityPulmonary MedicineAllergic RhinitisPharmacology